A "Molecular Condom" - A New Way to Deliver Anti-HIV Meds

University of Utah researcher Patrick Kiser is in the early stages of testing a new vaginal gel that if approved would halt HIV before it had a chance to enter vaginal tissue and infect the host. The "molecular condom" as they are calling it is a liquid at room temperature. When inserted into the vagina it becomes a semi-solid and then liquefies again when exposed to semen. Once liquid it attacks the HIV found in semen, inactivating it before it has a chance to enter surrounding tissue and infect the host. Read more about this unique approach to fighting HIV.

Related Items

Facts to be Aware of Before Having Unprotected Sex

Condom Do's and Dont's

Is vaginal Sex a Risk for HIV?

_{Photograph property of Judit Fabian - University of Utah}